Pelvic Floor Muscle Strength MeasurementNCT07320573
Evaluation of Pelvic Floor Muscle Strength in Women With Stress Urinary Incontinence
An observational study of Pelvic Floor Muscle Strength Measurement, run by Ahi Evran University Education and Research Hospital at 1 site in Turkey (Türkiye).
Trial summary
Pelvic floor muscle strength will be measured in women with stress urinary incontinence using superficial EMG, intravaginal EMG, and digital palpation. A 10-minute rest period will be given between each measurement, and the results will be recorded. Read more about this study
- Who is it for?
- Ages 18 to 70 years, women only
- Conditions the study is for
- Pelvic Floor Muscle Strength Measurement
- What is being tested?
- Electromyography
- Type of treatment
- Medical device
- How many people
- 25 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 25 Dec 2025to 15 Feb 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- Women only
- No healthy volunteers
- Adult, Older adult
Study population: Women with stress urinary incontinence
Who may be able to join
- Being over 18 years of age
- Having stress urinary incontinence
- Being willing to participate in the study
Who cannot join
- Unwillingness to continue working
- Presence of a neurological disease
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Kirşehir Ahi Evran University Physical Therapy and Rehabilitation Hospital
Kırşehir, Centre, 40000
About this study
Official title: Evaluation of Pelvic Floor Muscle Strength in Women With Stress Urinary Incontinence Using Two Different EMG Methods
Pelvic floor muscle strength will be measured in women with stress urinary incontinence using superficial EMG, intravaginal EMG, and digital palpation. A 10-minute rest period will be given between each measurement, and the results will be recorded. Once all measurements are completed, any differences between the three measurements will be examined.
Read the detailed description
Pelvic floor muscle strength will be assessed by vaginal palpation in the women included in the study. Then, patients will be placed in a hook position for EMG measurement. For superficial measurement, electrodes will be placed on the levator ani muscle on either side, and then the first assessment will be performed in 3 trials consisting of 5 seconds of contraction followed by 5 seconds of rest, and the second assessment in 3 trials consisting of 2 seconds of contraction followed by 5 seconds of rest.
Measurement with an intervaginal electrode will also be performed in the supine hook position, using a passive electrode and an active vaginal probe. Lubricant gel will be applied to the vaginal probe before insertion into the vagina, and the passive electrode will be placed on the inner surface of the right thigh (adductor muscle group). Two different protocols will be used for assessment. The first assessment will consist of 3 trials of 5 seconds of contraction followed by 5 seconds of rest, and the second assessment will consist of 3 trials of 2 seconds of contraction followed by 5 seconds of rest. A 10-minute rest period will be included between measurements. The ICIQ-SF questionnaire will also be used to determine the type and degree of incontinence. Participants will be asked to answer the questions considering the last two weeks. A score will then be assigned.
- Conditions
- Pelvic Floor Muscle Strength Measurement
- Being tested
- Electromyography
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ElectromyographyDevice
Muscle strength values will be obtained using surface electrodes.
| Study group | Role | What they receive |
|---|---|---|
| stress urinary incontinence | Pelvic floor muscle strength will be measured superficially, intravaginally, and digitally. Receives: Device: Electromyography |
What is being measured
The primary outcome is the main question the study is designed to answer.
pelvic floor muscle strength
muscle strength and endurance durations
Measured: day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Jan 2026
- Study start25 Dec 2025
- Primary completion25 Jan 2026
- Study completion15 Feb 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pelvic Floor Muscle Strength MeasurementStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 25 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ahi Evran University Education and Research Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Esra BAYRAMOĞLU DEMİRDÖĞEN, Ahi Evran University Education and Research Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07320573
- Sponsor's protocol ID
- KAEU-EBAYRAMOGLUD-004
- Status last verified
- Sep 2026
- First submitted
- 21 Dec 2025
- Last updated
- 22 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Pelvic Floor Muscle Strength in Women With Stress Urinary Incontinence Using Two Different EMG Methods
- ClinicalTrials.gov ID
- NCT07320573
- Acronym / sponsor ID
- KAEU-EBAYRAMOGLUD-004
- Conditions
- Pelvic Floor Muscle Strength Measurement
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 25 participants (actual)
- Lead sponsor
- Ahi Evran University Education and Research HospitalUniversity, hospital or other
- Study start
- 25 Dec 2025 (actual)
- Primary completion
- 25 Jan 2026 (actual)
- Study completion
- 15 Feb 2026 (actual)
- First posted
- 6 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pelvic floor muscle strength will be measured in women with stress urinary incontinence using superficial EMG, intravaginal EMG, and digital palpation. A 10-minute rest period will be given between each measurement, and the results will be recorded. Once all measurements are completed, any differences between the three measurements will be examined.
Detailed description
Pelvic floor muscle strength will be assessed by vaginal palpation in the women included in the study. Then, patients will be placed in a hook position for EMG measurement. For superficial measurement, electrodes will be placed on the levator ani muscle on either side, and then the first assessment will be performed in 3 trials consisting of 5 seconds of contraction followed by 5 seconds of rest, and the second assessment in 3 trials consisting of 2 seconds of contraction followed by 5 seconds of rest.
Measurement with an intervaginal electrode will also be performed in the supine hook position, using a passive electrode and an active vaginal probe. Lubricant gel will be applied to the vaginal probe before insertion into the vagina, and the passive electrode will be placed on the inner surface of the right thigh (adductor muscle group). Two different protocols will be used for assessment. The first assessment will consist of 3 trials of 5 seconds of contraction followed by 5 seconds of rest, and the second assessment will consist of 3 trials of 2 seconds of contraction followed by 5 seconds of rest. A 10-minute rest period will be included between measurements. The ICIQ-SF questionnaire will also be used to determine the type and degree of incontinence. Participants will be asked to answer the questions considering the last two weeks. A score will then be assigned.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| stress urinary incontinence | – | Device: ElectromyographyPelvic floor muscle strength will be measured superficially, intravaginally, and digitally. |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Women with stress urinary incontinence
Key inclusion criteria (3 listed)
- Being over 18 years of age
- Having stress urinary incontinence
- Being willing to participate in the study
Key exclusion criteria (2 listed)
- Unwillingness to continue working
- Presence of a neurological disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ElectromyographyMuscle strength values will be obtained using surface electrodes. | Device | stress urinary incontinence |
Primary outcome
pelvic floor muscle strength
Time frame: day 1
muscle strength and endurance durations
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Sep 2026.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pelvic Floor Muscle Strength Measurement, run by Ahi Evran University Education and Research Hospital at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
pelvic floor muscle strength (time frame: day 1). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2026.